S. Stokes et al. / Tetrahedron Letters 51 (2010) 4003–4006
4005
X
X
O
H
t
CO2 Bu
O
CO2tBu
Sn(OTf)2, DCM
H
X
MeO
MeO
MeO
MeO
MeO
MeO
N2
Rh2(OAc)4, DCM
O
O
O
1c
8 X = NO2, 64%
9 X = CN, 72%
X = H, 0%
6 X = NO2, 98%
7 X = CN, 77%
Scheme 2.
1H), 3.75 (s, 3H), 3.59 (s, 3H), 2.76 (d, J = 9.5 Hz, 1H), 2.41 (ddd, J = 9.5, 2.1 and
0.9 Hz, 1H), 1.47 (s, 9H); 13C NMR (300 mHz): d 169.8, 158.4, 155.5, 129.7, 119.5,
105.7, 100.3, 82.4, 68.7, 55.8, 52.2, 37.2, 29.8, 28.7, 28.3. 1-tert-Butyl 1-methyl
5,7-dimethoxy-1a,2-dihydrocyclopropa[c]chromene-1,1(7bH)-dicarboxylate (3b).
Yellow oil (296 mg, 78%); 1H NMR (300 MHz, CDCl3): d 6.15 (s, 1H), 5.90 (s,
1H), 4.12 (dd, 10.1 and 1.3 Hz, 1H), 3.97 (dd, 10.1 and 0.8 Hz, 1H), 3.82 (s, 3H),
3.81 (s, 3H), 3.79 (s, 3H), 2.50 (d, 9.0 Hz, 1H), 2.36 (dd, 9.0, 1.3 and 0.8 Hz), 1.35
(s, 9H); 13C NMR (300 mHz): d 170.0, 160.8, 157.9, 156.5, 104.4, 92.6, 91.8, 82.4,
68.6, 56.1, 55.8, 52.2, 37.5, 30.1, 28.5, 22.4. 1-tert-Butyl 1-methyl 5,6-dimethoxy-
1a,2-dihydrocyclopropa[c]chromene-1,1(7bH)-dicarboxylate (3c). Yellow oil
(315 mg, 83%); 1H NMR (300 MHz, CDCl3): d 6.85 (s, 1H), 6.41 (s, 1H), 4.05
(dd, J = 10.9 and 1.0 Hz, 1H), 3.93 (dd, J = 10.9 and 2.5 Hz, 1H), 3.83 (s, 3H), 3.80
(s, 3H), 3.76 (s, 3H), 2.70 (d, J = 9.2 Hz, 1H), 2.42 (ddd, J = 9.2, 2.5, and 1.0 Hz,
1H), 1.50 (s, 9H); 13C NMR (300 mHz): d 168.2, 147.8, 141.2, 120.5, 107.5,
100.2, 82.5, 68.4, 56.1, 52.5, 36.8, 29.5, 28.9, 28.2. tert-Butyl 1-cyano-5,6-
dimethoxy-1,1a,2,7b-tetrahydrocyclopropa[c]chromene-1-carboxylate (3d). White
solid (248 mg, 74% before recrystallized; 190 mg, 55% after recrystallization with
hexane and ethyl acetate); mp: 147–149 °C; 1H NMR (300 MHz, CDCl3): d 6.79
(s, 1H), 6.47 (s, 1H), 4.48 (dd, J = 12.2 and 2.0 Hz, 1H), 4.33 (dd, J = 12.2 and
3.6 Hz, 1H), 3.87 (s, 3H), 3.83 (s, 3H), 3.00 (d, J = 9.5 Hz, 1H), 2.61 (ddd,
J = 9.5,3.6, and 2.0 Hz, 1H), 1.54 (s, 9H); 13C NMR (300 mHz): d 165.0, 150.1,
147.1, 144.1, 115.0, 112.3, 107.2, 101.6, 84.5, 60.6, 56.4, 55.9, 30.7, 29.8, 27.9,
27.7. tert-Butyl 5,6-dimethoxy-1-(4-nitrophenyl)-1,1a,2,7b-tetrahydrocyclopropa
[c]chromene-1-carboxylate (6). Yellow oil (436 mg, 98%); 1H NMR (300 MHz,
CDCl3): d 7.99 (d, J = 8.7 Hz, 2H), 7.10 (d, J = 8.7 Hz, 2H), 6.89 (s, 1H), 5.98 (s,
1H), 4.39 (d, J = 11.7 Hz, 1H), 4.05 (dd, J = 11.8 and 2.2 Hz, 1H), 3.93 (s, 3H), 3.70
TsOH (not shown) gave complex mixtures of products and were
not analyzed further. All products 5a–d formed as single isomers
(see Fig. 1).
A single-crystal X-ray structure of compound 5c confirmed the
assigned stereochemistry of the lactone products, showing the
substituent X, in this case methyl ester, to be exo to the fused ring
system.15
A number of routes to
One commonly used method involves the
vated
-lactone using toxic lead- and mercury-based reagents.16c–e
To see if we could prepare these derivatives using our two-step
protocol, 2H-chromene 1c was reacted with three different
aryl- -diazo tert-butyl acetates to form cyclopropane intermedi-
a-aryl
c
-lactones have been reported.16
-arylation of an -acti-
a
a
c
a
-
a
ates (Scheme 2). Not surprisingly, our results indicated a direct
relationship between the yield of cyclopropane product and the
electron deficiency of the aryl ring on the diazo reagent and sug-
gested a need for the presence of an electron-withdrawing group
for the reaction to proceed. Notably, there was no evidence of an
insertion product in either of the successful cyclopropanations.
Moreover, both cyclopropane products 6 and 7 rearranged to
tones 8 and 9, respectively, on treatment with Sn(OTf)2.
c-lac-
(s, 3H), 2.96 (d, J = 9.7 Hz, 1H), 2.64 (dd, J = 9.7 and 1.4 Hz, 1H), 1.35 (s, 9H); 13
C
NMR (300 mHz): d 164.8, 147.8, 147.6, 145.6, 145.1, 141.2, 129.0, 123.7, 120.5,
107.5, 100.2, 82.7, 68.9, 55.9, 36.8, 36.6, 36.2, 28.7. tert-Butyl 1-(4-cyanophenyl)-
5,6-dimethoxy-1,1a,2,7b-tetrahydrocyclopropa[c]chromene-1-carboxylate (7). Yellow
oil (326 mg, 77%); 1H NMR (300 MHz, CDCl3): d 8.22 (d, J = 9.0 Hz, 2H), 7.65 (d,
J = 9.0 Hz, 2H), 6.90 (s, 1H), 5.99 (s, 1H), 4.39 (d, J = 11.1 Hz, 1H), 4.06 (d,
J = 11.1 Hz, 1H), 3.94 (s, 3H), 3.69 (s, 3H), 2.96 (d, J = 8.7 Hz, 1H), 2.64 (dd,
J = 8.7 and 1.0 Hz, 1H), 1.36 (s, 9H); 13C NMR (300 mHz): d 164.5, 147.8, 147.6,
143.8, 141.2, 132.0, 128.8, 120.5, 118.6, 109.8, 107.5, 100.2, 82.5, 68.7, 56.2,
36.9, 36.5, 36.1, 28.3.
A useful method for effecting successful c-lactonizations of 2H-
chromenes has been described, which avoids the use of strongly
oxidizing conditions. We hope to use these intermediates as tem-
plates for targeting novel flavan ring structures.
References and notes
13. For examples of cyclopropanations of alkenes with
a-trifluoromethyldiazo-
1. Fristad, W. E.; Peterson, J. R.; Ernst, A. B. J. Org. Chem. 1985, 50, 3143–3148.
2. del Rosario-Chow, M.; Ungwitayatorn, J.; Currie, B. L. Tetrahedron Lett. 1991, 32,
1011–1014.
3. (a) D’Annibale, A.; Trogolo, C. Tetrahedron Lett. 1994, 35, 2083–2086; (b)
Allegretti, M.; D’Annibale, A.; Trogolo, C. Tetrahedron 1993, 49, 10705–10714.
4. Cakir, S. P.; Mead, K. T.; Smith, L. Tetrahedron Lett. 2003, 44, 6355–6358.
5. Cakir, S. P.; Mead, K. T. J. Org. Chem. 2004, 69, 2203–2205.
6. Cakir, S. P.; Mead, K. Heterocycl. Commun. 2005, 11, 471–474.
phosphonate, see: Titanyuk, I. D.; Beletskaya, I. P.; Peregudov, A. S.; Osipov, S.
N. J. Fluorine Chem. 2007, 128, 723–728.
14. General procedure for the preparation of the lactones: methyl 7-methoxy-2-oxo-
3,3a,4,9b-tetrahydro-2H-furo[3,2-c]chromene-3-carboxylate (5a). In
a 5-mL
round-bottomed flask, solution of compound 3a (50 mg, 0.15 mmol) in
a
3 mL of dry DCM was cooled to 0 °C and tin(II) triflate (31 mg, 0.075 mmol) was
added. The reaction vessel was purged with argon and stirred overnight, slowly
allowing the solution to warm to room temperature. The reaction was
quenched with a few drops of water and then dried over MgSO4. The solvent
was removed under reduced pressure and then the crude product was purified
using flash column chromatography using mixtures of hexane and ethyl
acetate as the eluting solvents. Off-white solid (30 mg, 72%); 1H NMR
(300 MHz, CDCl3): d 7.28 (d, J = 8.6 Hz, 1H), 6.62 (dd, J = 8.6 and 2.4 Hz, 1H),
6.41 (d, J = 2.4 Hz, 1H), 5.68 (d, J = 7.3 Hz, 1H), 4.21 (dd, J = 11.8 and 3.4 Hz, 1H),
4.01 (dd, J = 11.8 and 6.2 Hz, 1H), 3.86 (s, 3H), 3.79 (s, 3H), 3.61 (d, J = 7.4 Hz,
1H), 3.43–3.35 (m, 1H); 13C NMR (300 mHz): d 171.0, 169.9, 158.1, 155.8,
128.7, 120.0, 108.6, 99.7, 81.1, 68.5, 55.8, 51.9, 49.5, 32.6. Methyl 7,9-
dimethoxy-2-oxo-3,3a,4,9b-tetrahydro-2H-furo[3,2-c]chromene-3-carboxylate
(5b). Off-white solid (24 mg, 57%); 1H NMR (300 MHz, CDCl3): d 6.17 (s, 1H),
5.98 (s, 1H), 5.62 (d, J = 7.0 Hz, 1H), 4.19 (dd, J = 11.3 and 3.8 Hz, 1H), 3.99 (dd,
J = 11.3 and 6.0 Hz, 1H), 3.88 (s, 3H), 3.85 (s, 3H), 3.83 (s, 3H), 3.63 (d, J = 7.5 Hz,
1H), 3.47–3.38 (m, 1H); 13C NMR (300 mHz): d 172.6, 165.3, 158.1, 146.2,
142.6, 111.78, 109.9, 100.3, 78.4, 65.1, 55.4, 55.0, 53.2, 48.6, 39.7. Methyl 7,8-
dimethoxy-2-oxo-3,3a,4,9b-tetrahydro-2H-furo[3,2-c]chromene-3-carboxylate
(5c). White solid (30 mg, 71%); mp: 149–150 °C; 1H NMR (300 MHz, CDCl3): d
6.79 (s, 1H), 6.42 (s, 1H), 5.67 (d, J = 7.4 Hz, 1H), 4.18 (dd, J = 11.8 and 3.3 Hz,
1H), 4.01 (dd, J = 11.8 and 5.9 Hz, 1H), 3.87 (s, 3H), 3.86 (s, 3H), 3.85 (s, 3H),
3.64 (d, J = 7.8 Hz, 1H), 3.43–3.35 (m, 1H); 13C NMR (300 mHz): d 170.6, 167.3,
151.1, 149.2, 144.7, 111.7, 109.2, 100.7, 73.8, 64.2, 56.3, 56.0, 53.4, 47.6, 38.2.
7,8-Dimethoxy-2-oxo-3,3a,4,9b-tetrahydro-2H-furo[3,2-c]chromene-3-carbonitrile
7. For previous routes to related 6,6,5-tricyclic
c-lactones, see: (a) Bentley, J.;
Nilsson, P. A.; Parsons, A. F. J. Chem. Soc., Perkin Trans. 1 2002, 12, 1461–1469;
(b) Kablaoui, N. M.; Hicks, F. A.; Buchwald, S. L. J. Am. Chem. Soc. 1997, 119,
4424–4431; (c) Szczepanik, M.; Obara, R.; Szumny, A.; Gabrys, B.; Halarewicz-
Pacan, A.; Nawrot, J.; Wawrzenczyk, C. J. Agric. Food. Chem. 2005, 53, 5905–
5910.
8. Kim, C.; Brady, T.; Kim, S. H.; Theodorakis, E. A. Synth. Commun. 2004, 34, 1951–
1965.
9. Davies, H. M. L.; Hu, B. J. Org. Chem. 1992, 57, 4309–4312.
10. Blanchard, L. A.; Schneider, J. A. J. Org. Chem. 1986, 51, 1372–1374.
11. For a review, see: Davies, H. M. L.; Antoulinakis, E. G. Org. React. 2001, 57, 1.
12. General procedure for formation of the cyclopropanes: 1-tert-butyl 1-methyl 5-
methoxy-1a,2-dihydrocyclopropa[c]chromene-1,1(7bH)-dicarboxylate (3a). In a 5-
mL round-bottomed flask, 7-methoxy-2H-chromene (200 mg, 1.2 mmol) was
dissolved in 2 mL of dry DCM. Once dissolution was achieved, Rh2(OAc)4 (11 mg,
0.024 mmol) was added and the reaction vessel was purged with argon. This
mixture was stirred for 5 min and then 1-tert-butyl 3-methyl 2-diazomalonate
(480 mg, 2.4 mmol) dissolved in 1 mL of dry DCM was added via a syringe pump
over 5 h. The solvent was removed under reduced pressure and the crude
product was purified by flash column chromatography using mixtures of hexane
and ethyl acetate as the eluting solvents. Yellow oil (253 mg, 63%); 1H NMR
(300 MHz, CDCl3): d 7.21 (d, J = 8.4 Hz, 1H), 6.54 (dd, J = 8.4 and 2.6 Hz, 1H), 6.34
(d, J = 2.5 Hz, 1H), 4.52 (dd, J = 11.3 and 0.9 Hz, 1H), 3.98 (dd, J = 11.3 and 2.1 Hz,